Thompson Davis & Co., Inc. Natera, Inc. Transaction History

Thompson Davis & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $21,565 - $29,750	-250 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $4,705 - $7,240	250 New	250 $6,000
Q2 2018 Aug 03, 2018	SELL	$8.79 - $19.98 $3,296 - $7,492	-375 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$9.0 - $11.95 $3,375 - $4,481	375 New	375 $3,000
Q4 2017 Feb 05, 2018	SELL	$8.99 - $14.31 $42,702 - $67,972	-4,750 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$8.02 - $13.33 $38,095 - $63,317	4,750	4,750 $61,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.